News
-
AstraZeneca has entered into a multi-year agreement with Galapagos subsidiaries BioFocus and Argenta to collaborate on discovery of compounds for the treatment of respiratory and inflammatory diseases. The deal allows AstraZeneca the use of Argenta’s… Read more . . .
-
Alexza Pharmaceuticals, whose lead product, Adasuve Staccato loxapine is under review by the FDA and the EMA, has reported a net loss of $40.5 million for the year ended December 31, 2011. The company also… Read more . . .
-
Nycomed says that it is now marketing its Omnaris ciclesonide nasal spray for the treatment of allergic rhinitis in the United Arab Emirates (UAE). The company, a subsidiary of Takeda, says that it will launch… Read more . . .
-
The FDA has cleared Aradigm’s Investigational New Drug Application (IND) for a Phase 3 clinical trial of Pulmaquin dual release ciprofloxacin for inhalation in non-cystic fibrosis bronchiectasis. The Phase 3 program include two one-year placebo-controlled… Read more . . .
-
Hovione has appointed Colin Minchom, formerly Patheon’s VP of Pharmaceutical Development Services for North America, as VP of its Particle Design Business Unit. Minchom has almost 30 years experience in drug development, especially in dosage… Read more . . .
-
The FDA has approved Teva’s ProAir HFA albuterol metered dose inhaler with a dose counter for the treatment and prevention of bronchospasm in patients 4 years of age and older. According to the company, the… Read more . . .
-
Specialty pharmaceutical manufacturer Hi-Tech Pharmacal will pay a total of $2.5 million plus up to to $1.75 million in royalties to Dynova Laboratories for a line of homeopathic nasal sprays including the Sinus Buster and… Read more . . .
-
September 11-12 in Munich. Prospective speakers should submit proposals to camilla.perselli@informa.com. Topics are “Innovations in oral and nasal inhalation devices” and “Predicting commercial viability for inhalation drug development.” Read more . . .
-
The FDA has issued a warning letter to Breathable Foods, the manufacturer of AeroShot inhalable caffeine for “false or misleading statements in the labeling of their product.” The agency is also questioning the safety of… Read more . . .
-
Powder characterization specialist Freeman Technology has established a US subsidiary, Freeman Technology Inc., to handle the growing North American demand for its FT4 powder rheometer. Newly-hired National Sales Specialist Mike Delancey and Applications Specialist John… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan